299 related articles for article (PubMed ID: 31353426)
1. Debate on Insulin vs Non-insulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?
Pasquel FJ; Fayfman M; Umpierrez GE
Curr Diab Rep; 2019 Jul; 19(9):65. PubMed ID: 31353426
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close.
Koufakis T; Mustafa OG; Zebekakis P; Kotsa K
Diabet Med; 2020 Sep; 37(9):1418-1426. PubMed ID: 32445407
[TBL] [Abstract][Full Text] [Related]
3. Transitioning from inpatient to outpatient therapy in patients with in-hospital hyperglycemia.
Peterson G
Hosp Pract (1995); 2011 Oct; 39(4):87-95. PubMed ID: 22056828
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study.
Pérez-Belmonte LM; Osuna-Sánchez J; Millán-Gómez M; López-Carmona MD; Gómez-Doblas JJ; Cobos-Palacios L; Sanz-Cánovas J; Barbancho MA; Lara JP; Jiménez-Navarro M; Bernal-López MR; Gómez-Huelgas R
Ann Med; 2019; 51(3-4):252-261. PubMed ID: 31037970
[No Abstract] [Full Text] [Related]
5. Complementing insulin therapy to achieve glycemic control.
Barnett AH
Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
[TBL] [Abstract][Full Text] [Related]
6. Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.
Schwartz SS; DeFronzo RA; Umpierrez GE
Postgrad Med; 2015 Mar; 127(2):251-7. PubMed ID: 25547241
[TBL] [Abstract][Full Text] [Related]
7. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
8. Management of Inpatient Hyperglycemia and Diabetes in Older Adults.
Umpierrez GE; Pasquel FJ
Diabetes Care; 2017 Apr; 40(4):509-517. PubMed ID: 28325798
[TBL] [Abstract][Full Text] [Related]
9. Insulin Therapy in Type 2 Diabetes.
Aschner P
Am J Ther; 2020; 27(1):e79-e90. PubMed ID: 31567175
[TBL] [Abstract][Full Text] [Related]
10. Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.
Bode B; Amin A
Hosp Pract (1995); 2009 Dec; 37(1):7-21. PubMed ID: 20720383
[TBL] [Abstract][Full Text] [Related]
11. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
Kumar A
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
[TBL] [Abstract][Full Text] [Related]
12. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
13. Alogliptin benzoate for management of type 2 diabetes.
Saisho Y
Vasc Health Risk Manag; 2015; 11():229-43. PubMed ID: 25914541
[TBL] [Abstract][Full Text] [Related]
14. Use of incretin-based therapy in hospitalized patients with hyperglycemia.
Umpierrez GE; Schwartz S
Endocr Pract; 2014 Sep; 20(9):933-44. PubMed ID: 25100362
[TBL] [Abstract][Full Text] [Related]
15. Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents.
Blonde L; Montanya E
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():20-32. PubMed ID: 22405266
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF; Mannucci E; Ahrén B
Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
[TBL] [Abstract][Full Text] [Related]
17. [Optimizing basal insulin therapy in type 2 diabetes].
Scheen AJ; Paquot N
Rev Med Liege; 2017 Mar; 72(3):156-161. PubMed ID: 28387494
[TBL] [Abstract][Full Text] [Related]
18. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.
Barnett AH; Charbonnel B; Moses RG; Kalra S
Curr Med Res Opin; 2015; 31(10):1919-31. PubMed ID: 26361231
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.
Liu Y; Hong T
Diabetes Obes Metab; 2014 Feb; 16(2):111-7. PubMed ID: 23668534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
